MacroGenics specializes in the discovery and development of next‑generation antibody‑based therapeutics, with a robust pipeline focused on oncology, autoimmune disorders, and infectious diseases. The company leverages cutting‑edge technologies such as bi‑specific antibodies, Fc optimization, and monoclonal antibody platforms to create innovative medicines that address unmet medical needs. MacroGenics has forged strategic partnerships with leading pharmaceutical and biotechnology firms worldwide, amplifying its research impact and accelerating product development. With a dedicated team of over 300 professionals, the company fosters a culture of innovation, open communication, and teamwork, positioning employees as its most valuable asset.
The Senior Scientist II is a key member of the Cell Culture Sciences team in the BioPharmaceutical Development (BPD) department, responsible for Cell Line Development (CLD) functions, including generation of cell lines that produce recombinant protein molecules in mammalian cells.
MacroGenics specializes in the discovery and development of next‑generation antibody‑based therapeutics, with a robust pipeline focused on oncology, autoimmune disorders, and infectious diseases. The company leverages cutting‑edge technologies such as bi‑specific antibodies, Fc optimization, and monoclonal antibody platforms to create innovative medicines that address unmet medical needs. MacroGenics has forged strategic partnerships with leading pharmaceutical and biotechnology firms worldwide, amplifying its research impact and accelerating product development. With a dedicated team of over 300 professionals, the company fosters a culture of innovation, open communication, and teamwork, positioning employees as its most valuable asset.
Cellares